States Fear Price Of New Zika Vaccine Will Be More Than They Can Pay
The vaccine against Zika vaccine was developed by the Army, with the government paying for clinical trials, too. Health officials want to be sure drugmaker Sanofi Pasteur doesn't make it unaffordable.
by Alison Kodjak
May 30, 2017
4 minutes
The U.S. Army is planning to grant an exclusive license to the French pharmaceutical company Sanofi Pasteur, Inc. to manufacture and sell a Zika vaccine the Army developed last year.
And that has Rebekah Gee, Louisiana's secretary of health, worried about paying for it.
"God forbid we have a Zika outbreak. We're in the middle of a fiscal crisis, we're already cutting services to people and we're already potentially cutting our funding to fight the Zika virus," Gee says.
If the Army goes through with its plan, she says, Sanofi could set a price for the vaccine at a level that Louisianans just won't be able to afford.
Gee is among a growing number of
You’re reading a preview, subscribe to read more.
Start your free 30 days